These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease. Charles SJ, Gray JJ. Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190 [Abstract] [Full Text] [Related]
3. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation. Venard V, Dauendorffer JN, Carret AS, Corsaro D, Edert D, Bordigoni P, Le Faou A. Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018 [Abstract] [Full Text] [Related]
4. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS. Marks GL, Nolan PE, Erlich KS, Ellis MN. Rev Infect Dis; 1989 Sep; 11(3):474-6. PubMed ID: 2546244 [Abstract] [Full Text] [Related]
5. [Resistance of herpes simplex viruses to antiviral drugs]. Scieux C, Bianchi A. Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160 [Abstract] [Full Text] [Related]
6. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient. Schnipper LE, Crumpacker CS, Marlowe SI, Kowalsky P, Hershey BJ, Levin MJ. Am J Med; 1982 Jul 20; 73(1A):387-92. PubMed ID: 6285729 [Abstract] [Full Text] [Related]
7. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients]. Jansen CL, Maris-Tegeler WG, Wertheim-van Dillen PM, Frissen PH, Weiland HT, van der Noordaa J. Ned Tijdschr Geneeskd; 1992 Feb 08; 136(6):280-4. PubMed ID: 1311058 [Abstract] [Full Text] [Related]
8. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome. Birch CJ, Tachedjian G, Doherty RR, Hayes K, Gust ID. J Infect Dis; 1990 Sep 08; 162(3):731-4. PubMed ID: 2167340 [Abstract] [Full Text] [Related]
9. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient. Arnulf B, Chebbi F, Lefrere F, Ait Arkoub Z, Varet B, Fillet AM. Bone Marrow Transplant; 2001 Oct 08; 28(8):799-801. PubMed ID: 11781635 [Abstract] [Full Text] [Related]
10. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. Safrin S, Assaykeen T, Follansbee S, Mills J. J Infect Dis; 1990 Jun 08; 161(6):1078-84. PubMed ID: 2161035 [Abstract] [Full Text] [Related]
11. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. Saijo M, Yasuda Y, Yabe H, Kato S, Suzutani T, De Clercq E, Niikura M, Maeda A, Kurane I, Morikawa S. J Med Virol; 2002 Sep 08; 68(1):99-104. PubMed ID: 12210436 [Abstract] [Full Text] [Related]
12. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs. Field H, McMillan A, Darby G. J Infect Dis; 1981 Feb 08; 143(2):281-5. PubMed ID: 6260876 [Abstract] [Full Text] [Related]
13. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation. Iino T, Gondo H, Ohno Y, Minagawa H, Iwasaki H, Maruyama T, Nakashima H, Niho Y. Bone Marrow Transplant; 1996 Dec 08; 18(6):1185-8. PubMed ID: 8971394 [Abstract] [Full Text] [Related]
14. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient. Christophers J, Sutton RN. J Antimicrob Chemother; 1987 Sep 08; 20(3):389-98. PubMed ID: 2824424 [Abstract] [Full Text] [Related]
15. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J. N Engl J Med; 1991 Aug 22; 325(8):551-5. PubMed ID: 1649971 [Abstract] [Full Text] [Related]
16. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT. Verdonck LF, Cornelissen JJ, Smit J, Lepoutre J, de Gast GC, Dekker AW, Rozenberg-Arska M. Bone Marrow Transplant; 1993 Feb 22; 11(2):177-9. PubMed ID: 8382096 [Abstract] [Full Text] [Related]
17. Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet. Pelosi E, Hicks KA, Sacks SL, Coen DM. Adv Exp Med Biol; 1992 Feb 22; 312():151-8. PubMed ID: 1325102 [Abstract] [Full Text] [Related]
18. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. Balfour HH, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S. J Acquir Immune Defic Syndr (1988); 1994 Mar 22; 7(3):254-60. PubMed ID: 8106965 [Abstract] [Full Text] [Related]
19. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed. Schmit I, Boivin G. J Infect Dis; 1999 Aug 22; 180(2):487-90. PubMed ID: 10395866 [Abstract] [Full Text] [Related]
20. Suppression of infectious virus spread to the liver by foscarnet following lethal infection of acyclovir-resistant herpes simplex virus type 2 in mice. Li YY, Minagawa H, Tanaka S, Mori R. Antiviral Res; 1995 May 22; 27(1-2):111-21. PubMed ID: 7486949 [Abstract] [Full Text] [Related] Page: [Next] [New Search]